A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma
Open Access
- 30 August 2024
- journal article
- Published by Elsevier in Journal of Advanced Research
- Vol. 73, 341-356
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education
- National Research Foundation of Korea
- National Medical Research Council (MOH-OFIRG19nov-0012)
- Ministry of Science ICT and Future Planning (NRF-2021R1I1A2060024)
- Council for Scientific and Industrial Research, South Africa (09/119(0220)2019EMR-I)
This publication has 50 references indexed in Scilit:
- Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cellsJournal of Cellular Biochemistry, 2024
- A new triazolyl‐indolo‐quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεCDrug Development Research, 2023
- Numerical solutions and geometric attractors of a fractional model of the cancer-immune based on the Atangana-Baleanu-Caputo derivative and the reproducing kernel schemeChinese Journal of Physics, 2022
- Pharmacological properties of indirubin and its derivativesBiomedicine & Pharmacotherapy, 2022
- Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastineBiomedicine & Pharmacotherapy, 2018
- Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo [1,5-a] pyrimidines in human breast cancer cellsBioorganic & Medicinal Chemistry Letters, 2018
- Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatmentCancer Letters, 2016
- Synthesis of 1,2-benzisoxazole tethered 1,2,3-triazoles that exhibit anticancer activity in acute myeloid leukemia cell lines by inhibiting histone deacetylases, and inducing p21 and tubulin acetylationBioorganic & Medicinal Chemistry, 2015
- The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancerBiochemical Pharmacology, 2014
- The clinical value of hepatocyte growth factor and its receptor—c-met for liver cancer patients with hepatectomyDigestive and Liver Disease, 2006